. . . . "Oral LD₅₀ Mouse : 16500 mg/kg. Side effects include moderate to severe erythema (redness) and moderate edema (raised kin), nausea, vomiting, headache, dizziness, and tiredness. Higher exposure causes unconsciousness."@en . . . . "N(1)-Acetylsulfanilamide"@en . . . . . . . . . . "Sulfac\u00E9tamide"@en . . . "N-(P-Aminobenzenesulfonyl)acetamide"@en . . . . . . . . . . . . . . . . . . . . . "7-12.8 hours"@en . "Sulfacetamida"@en . "N-Acetylsulfanilamide"@en . . . "P-Aminobenzenesulfonacetamide"@en . "N-Sulfanilylacetamide"@en . . . . . . . "An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections. [PubChem]"@en . . . . "Sulfanilazetamid"@en . . "Sulphacetamidum"@en . . . . . . "N-[(P-Aminophenyl)sulfonyl]acetamide"@en . . . . . . . . . . . . . . . . . "Sulphacetamide"@en . . . . . . . . . . . . . . . . "Enteric bacteria and other eubacteria"@en . . . " "@en . . . . . . "Sulfacetamide is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), an essential component for bacterial growth (according to the Woods-Fildes theory). The inhibited reaction is necessary in these organisms for the synthesis of folic acid."@en . "# Hull CA, Johnson SM: A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor. Cutis. 2004 Jun;73(6):425-9. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/15224788 # Del Rosso JQ: Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. Cutis. 2004 Jan;73(1 Suppl):29-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/14959943 # Roth HW, Leimbeck R, Sonnenschein B, Anger CB, Weber S: [The effective antibacterial spectrum of sulfacetamide] Klin Monatsbl Augenheilkd. 1992 Mar;200(3):182-6. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1578876"@en . . "Acetosulfamine"@en . . . . . "Sulfacetamid"@en . . "Sulfacetamide"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "N-Acetyl-4-aminobenzenesulfonamide"@en . . . . . . . . "N-((P-Aminophenyl)sulfonyl)acetamide"@en . . . . . . . "N-Sulphanilylacetamide"@en . . . . . "N(1)-Acetyl-4-aminophenylsulfonamide"@en . . "P-Aminobenzenesulfonoacetamide"@en . "Sulfacetamidum"@en . " "@en . . . . . "For the treatment of bacterial vaginitis, keratitis, acute conjunctivitis, and blepharitis."@en . . . "approved"@en . "N'-acetylsulfanilamide"@en . . . . . . . . . "144-80-9"@en . .